tm logo
Live/Registered
REGISTERED

on 10 Jan 2023

Last Applicant/ Owned by

NL-3721 MA Bilthoven

NL

Serial Number

79328029 filed on 12th Jul 2021

Registration Number

6945296 registered on 10th Jan 2023

in the Principal Register

Correspondent Address

Jeffrey H. Greger

Hauptman Ham, LLP

SUITE 1400

2318 MILL RD.

Alexandria VA 22314

Filing Basis

No Filing Basis

Disclaimer

NO DATA

Logo Mark Trademark Information

Biological, clinical and medical research in the field of bacterial and viral vaccines and bacterial and viral vaccine technology as well as therapeutic vaccines against allergic diseases and cancer and related vaccine technology; biological, clinical and medical research and development in the field of synthetic and therapeutic vaccines and synthetic and therapeutic vaccine technology; clinical aRead More

Classification Information


Class [041]
Education and Entertainment Services


Publication of medical texts and journals, magazines and articles in the field of cancer, infectious diseases and allergic diseases and immune therapy of diseases, bacterial and viral vaccines, synthetic and therapeutic vaccines; educational services, namely, providing training and seminars in the field of vaccines and medicines; organizing educational and informative meetings and conferences in the field of vaccines and medicines; training in use and administering of vaccines and medicines

Class [010]
Medical Instrument Products


Cups for dispensing medicine; injection needles for the administration of vaccines and medicines; injection instruments without needles for the administration of vaccines and medicines

Class [042]
Computer & Software Services & Scientific Services


Biological, clinical and medical research in the field of bacterial and viral vaccines and bacterial and viral vaccine technology as well as therapeutic vaccines against allergic diseases and cancer and related vaccine technology; biological, clinical and medical research and development in the field of synthetic and therapeutic vaccines and synthetic and therapeutic vaccine technology; clinical and preclinical research in the field of immunology, namely, the safety and immunogenicity of candidate vaccine in humans; testing of vaccines and medicines; research in the field of new and existing vaccines and medicines; services of a scientific laboratory; conducting clinical trials and testing; scientific research for medical purposes

Class [005]
Pharmaceutical Products


Pharmaceutical products and preparations for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases and allergic diseases, as well as pharmaceutical products and preparations against cancer; vaccines; medicines for human use for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases, allergic diseases and cancer; bacterial and viral vaccines, synthetic, recombinant, peptide, protein, rna-, dna- and therapeutic vaccines

Mark Details


Serial Number

No 79328029

Mark Type

No Service Mark

Attorney Docket Number

No 6693-009TM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.03.16 -

Ovals touching or intersecting

26.03.17 -

Concentric ovals and ovals within ovals

26.03.21 -

Ovals that are completely or partially shaded

Description of Design Search

The mark consists of a greenish yellow oval with an overlaid blue oval containing two irregular oval shaped cutouts.

Legal History


Show more

Status DateAction Taken
24th May 2023IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
26th Apr 2023FINAL DISPOSITION NOTICE SENT TO IB
25th Apr 2023FINAL DISPOSITION PROCESSED
10th Apr 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10th Jan 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
10th Jan 2023REGISTERED-PRINCIPAL REGISTER
25th Oct 2022PUBLISHED FOR OPPOSITION
25th Oct 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Oct 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16th Sep 2022APPROVED FOR PUB - PRINCIPAL REGISTER